Poliakova Natalia, Shrier Lydia A, Harris Sion Kim, Bélanger Richard E
Research Centre of CHU de Québec-Université Laval, Quebec City, QC, Canada.
Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Tob Use Insights. 2024 Jun 5;17:1179173X241259603. doi: 10.1177/1179173X241259603. eCollection 2024.
Cannabis is frequently co-used with tobacco/nicotine products, especially among young adults. Little is known about the effects of this co-use on cannabis cessation outcomes. Within a sample of young adults using cannabis frequently (current use of ≥5 days/week in the past 3 months), this study aimed to (a) document sources of exposure to tobacco/nicotine products, whether used simultaneously with cannabis or on different occasions, (b) examine if the level of cumulated exposure to tobacco/nicotine (self-reported or from biochemical testing) could predict time to cannabis lapse during a cannabis abstinence period, and (c) explore the relationship between nicotine/tobacco exposure and time to cannabis lapse according to tobacco cigarette smoking status. Urine cotinine measures and self-reported data on use of different tobacco/nicotine products, collected from 32 participants (aged 19 to 23), were analyzed to predict time to lapse during a 2-week period of attempted abstinence from cannabis, controlling for cannabis dependence and sex. Half of participants (56.3%) used at least one tobacco/nicotine product. Higher urine cotinine, representing higher cumulated tobacco/nicotine exposure, was related to a higher risk of lapsing (Hazard Ratio [HR] = 1.64; 95%CI [1.04, 2.58]). The risk of lapsing was even higher ([HR] = 3.46; 95%CI [1.17, 10.25]) among heavily tobacco/nicotine exposed (>600 ng/mL, urine cotinine) participants than among unexposed (<50 ng/mL) or lightly/moderately exposed (50-600 ng/mL) participants. Among those smoking cigarettes (solely or in combination with other products), there was no relation between cotinine level and time to lapse, likely due to a reduced variability in abstinence probability and a high likelihood of lapse observed for higher cotinine levels, mainly achieved by cigarette use. With a rapidly changing landscape of tobacco/nicotine use, our results underscore the need to consider all sources of tobacco/nicotine exposure to fully understand the specific and cumulative contributions of tobacco/nicotine to cannabis cessation outcomes.
大麻经常与烟草/尼古丁产品同时使用,尤其是在年轻人中。对于这种同时使用对大麻戒断结果的影响知之甚少。在一个经常使用大麻的年轻人群样本中(过去3个月内每周使用≥5天),本研究旨在:(a)记录接触烟草/尼古丁产品的来源,无论其是与大麻同时使用还是在不同场合使用;(b)检查累积接触烟草/尼古丁的水平(自我报告或通过生化检测)是否可以预测大麻戒断期间复吸的时间;(c)根据吸烟状况探讨尼古丁/烟草接触与大麻复吸时间之间的关系。对从32名参与者(年龄在19至23岁之间)收集的尿可替宁测量值以及关于不同烟草/尼古丁产品使用情况的自我报告数据进行分析,以预测在尝试戒断大麻的2周期间复吸的时间,并对大麻依赖和性别进行控制。一半的参与者(56.3%)使用了至少一种烟草/尼古丁产品。较高的尿可替宁水平代表较高的累积烟草/尼古丁接触,与复吸风险较高相关(风险比[HR]=1.64;95%置信区间[1.04, 2.58])。在大量接触烟草/尼古丁(尿可替宁>600 ng/mL)的参与者中,复吸风险甚至更高([HR]=3.46;95%置信区间[1.17, 10.25]),高于未接触(<50 ng/mL)或轻度/中度接触(50 - 600 ng/mL)的参与者。在那些吸烟(单独或与其他产品一起)者中,可替宁水平与复吸时间之间没有关系,这可能是由于戒断概率的变异性降低以及在较高可替宁水平下观察到的复吸可能性较高,主要是通过吸烟实现的。随着烟草/尼古丁使用情况的迅速变化,我们的结果强调需要考虑所有烟草/尼古丁接触来源,以充分了解烟草/尼古丁对大麻戒断结果的具体和累积贡献。